NOT KNOWN DETAILS ABOUT BRD4 INHIBITION BY ABBV-744 IN CANCER RESEARCH STUDIES

Supplemental studies in progress counsel that ARV-825 may also be effective in boosting the response to estrogen deprivation (aromatase inhibition), another component of ordinary of care in ER+ breast cancer.and then boost H3K27Ac at this location. Chromatin hyperacetylation could improve the accessibility in the transcriptional regulatory sites an